COMMUNIQUÉS West-GlobeNewswire

-
JSC Olainfarm Strengthens the Boards of Several Daughter Companies
30/11/2018 -
Coherus BioSciences Announces Apexus Contract Agreement for 340B Hospitals and Clinics, and Q-Code Issuance from CMS
30/11/2018 -
HEXO scoops two prizes at 2018 Canadian Cannabis Awards
30/11/2018 -
HEXO remporte deux prix aux Canadian Cannabis Awards 2018
30/11/2018 -
Clementia Announces the Departure of Chief Commercial Officer
30/11/2018 -
Clementia annonce le départ de son chef de la direction commerciale
30/11/2018 -
WW to Present at Nasdaq 39th Investor Conference
30/11/2018 -
Xenon Pharmaceuticals to Host Conference Call and Webcast to Provide Corporate Update and Overview of Presentations at the 2018 American Epilepsy Society (AES) Meeting
30/11/2018 -
Radius Health Provides Updates on its Oncology Programs and Announces Scientific Presentations at 2018 San Antonio Breast Cancer Symposium (SABCS)
30/11/2018 -
Glass Lewis Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
30/11/2018 -
Agility Health Reports Third Quarter 2018 Financial Results
30/11/2018 -
Holding(s) in Company
30/11/2018 -
Vilacto Bio Secured Patent Applications for LACTOACTIVE®
30/11/2018 -
Assure Holdings Announces Results of Annual General Meeting of Shareholders
30/11/2018 -
Wildflower Posts 9th Consecutive Quarter With Increased Revenue
30/11/2018 -
SELLAS to Present Further Correlative Data from Phase 2b Trial of NeuVax + Herceptin® at the 2018 San Antonio Breast Cancer Symposium
30/11/2018 -
Oncology Venture A/S: Publication of financial report Q3 2018
30/11/2018 -
Cocrystal Pharma Announces Presentation at the RespiDART 2018: Frontiers in Drug Development Against Respiratory Viruses Conference
30/11/2018 -
IntelGenx Engages Focus Communications for Investor Relations Program
30/11/2018
Pages